Washington, March 4 – The U.S. International Trade Commission (USITC) has received a complaint alleging that versions of the cancer drug pertuzumab, which are biosimilars, imported into the United States violate U.S. trade law.Several entities of India’s largest biopharmaceutical company...
bioconbiologics inc.
bioconbiologicsinternationalltd.bioconbiologicsltd.bioconbiologics uk plc
bioconltd.
biosimilars
breast cancer treatment
genentech
importation
monoclonal antibody
pertuzumab
section 337 tariff act of 1930
trade remedies
united states international trade commission
usitc